🚚 FREE U.S. Shipping on Orders Over $500
SKU: TB500-10mg

TB-500 (THYMOSIN BETA-4) 43aa (10mg)

TB-500 (Thymosin Beta-4) is supplied as the complete 43-residue thymosin beta-4 sequence, N-terminally acetylated, prepared synthetically for laboratory use. Thymosin beta-4 is the principal G-actin sequestering polypeptide described in vertebrate cells. It binds actin monomers through the conserved LKKTETQ motif at residues 17 to 23 and maintains a pool of unpolymerized actin in cell-free and cultured systems. Laboratory interest centers on actin binding and the regulation of cytoskeletal assembly.

 

Compound Specifications

Product Name TB-500 (Thymosin Beta-4) 43aa
Technical Name Thymosin beta-4, N-terminally acetylated
Other Names TB-500, TB500, Thymosin Beta-4, Tbeta4
Sequence Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES
Residue Count 43
Molecular Formula C212H350N56O78S
Molecular Weight 4963.5 g/mol
CAS Number 77591-33-4
Peptide Class Beta-thymosin, actin-binding polypeptide
Appearance White to off-white lyophilized powder

 

Storage & Handling
Store the lyophilized powder in a sealed container at −20 °C, protected from light and moisture. After reconstitution, store the solution at 2–8 °C and use it promptly. Avoid repeated freeze–thaw cycles. Use aseptic technique to preserve compound integrity and follow standard laboratory safety practices.

FOR RESEARCH USE ONLY. Not for human consumption. Not intended for human or veterinary use. For laboratory research and analytical purposes only.

 

 

$95.00

Choose Quantity

Description

TB-500 (Thymosin Beta-4) is supplied as the complete 43-residue thymosin beta-4 sequence, N-terminally acetylated, prepared synthetically for laboratory use. Thymosin beta-4 is the principal G-actin sequestering polypeptide described in vertebrate cells. It binds actin monomers through the conserved LKKTETQ motif at residues 17 to 23 and maintains a pool of unpolymerized actin in cell-free and cultured systems. Laboratory interest centers on actin binding and the regulation of cytoskeletal assembly.

 

Compound Specifications

Product Name TB-500 (Thymosin Beta-4) 43aa
Technical Name Thymosin beta-4, N-terminally acetylated
Other Names TB-500, TB500, Thymosin Beta-4, Tbeta4
Sequence Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES
Residue Count 43
Molecular Formula C212H350N56O78S
Molecular Weight 4963.5 g/mol
CAS Number 77591-33-4
Peptide Class Beta-thymosin, actin-binding polypeptide
Appearance White to off-white lyophilized powder

 

Storage & Handling
Store the lyophilized powder in a sealed container at −20 °C, protected from light and moisture. After reconstitution, store the solution at 2–8 °C and use it promptly. Avoid repeated freeze–thaw cycles. Use aseptic technique to preserve compound integrity and follow standard laboratory safety practices.

FOR RESEARCH USE ONLY. Not for human consumption. Not intended for human or veterinary use. For laboratory research and analytical purposes only.

 

 

Additional information

Weight 0.1 lbs
Dimensions 1 × 1 × 2 in

Disclaimer: For Research Purposes Only

This content is supplied exclusively for research and educational purposes. Nothing presented here should be interpreted as approval, promotion, or encouragement of any non-laboratory use, improper handling, or non-research application of peptides intended for scientific investigation. Any references to specific peptides, their properties, or findings associated with them are provided solely as informational research content. This information does not constitute legal advice, clinical guidance, or a recommendation for personal, therapeutic, or non-research use. These compounds are intended only for controlled scientific work conducted by qualified and authorized individuals. Before making any decision regarding the purchase, possession, handling, or use of research peptides, consultation with qualified research professionals or legal counsel is strongly advised. All information should be used responsibly, ethically, and only in connection with legitimate academic, scientific, or investigative purposes. This notice applies broadly to all peptide-related content provided here and may be updated as needed.

0